Indian benchmark indices closed with marginal gains today, as the Nifty index maintained its position above the 24,600 mark.
The BSE Sensex rose by 16.09 points (0.02%) to close at 81,526.14, while the Nifty gained 31.75 points (0.13%) to settle at 24,641.80. Several companies witnessed impressive performances, hitting their respective 52-week highs. Here’s a roundup of the stocks that achieved this milestone:
1. Central Depository Services (India)
Central Depository Services (India) saw a rise in its stock price, reaching a new 52-week high of ₹1,935.30.
2. Kaynes Technology India
Kaynes Technology India surged to ₹6,524.20, marking a fresh 52-week high.
3. UTI Asset Management Company
UTI Asset Management Company reached a new 52-week high of ₹1,400.00.
4. Piramal Enterprises
Piramal Enterprises hit a new 52-week high of ₹1,275.00.
5. Max Healthcare Institute
Max Healthcare Institute reached a new 52-week high of ₹1,137.00.
6. LTIMindtree
LTIMindtree, a leading IT services and consulting company, achieved a 52-week high of ₹6,642.65.
7. Jubilant Ingrevia
Jubilant Ingrevia rose to a new 52-week high of ₹859.15.
8. Indian Hotels Company
Indian Hotels Company hit a new 52-week high of ₹846.45.
9. 360 One Wam
360 One Wam achieved a 52-week high of ₹1,225.95.
10. EID-Parry (India)
EID-Parry (India) surged to a new 52-week high of ₹926.80.
11. Lloyds Metals & Energy
Lloyds Metals & Energy reached a new 52-week high of ₹1,139.45.
12. Vedanta
Vedanta saw its stock price hit a new 52-week high of ₹525.00.
13. Swan Energy
Swan Energy surged to a new 52-week high of ₹796.70.
14. Nippon Life India Asset Management
Nippon Life India Asset Management reached a new 52-week high of ₹816.25.
15. Bajaj Holdings & Investment
Bajaj Holdings & Investment hit a new 52-week high of ₹11,545.90.
16. Eris Lifesciences
Eris Lifesciences achieved a new 52-week high of ₹1,593.90.
17. Nuvama Wealth Management
Nuvama Wealth Management reached a new 52-week high of ₹7,648.00.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
